Cosmina S Hogea (Cosmina Hogea)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Acute Lymphoblastic Leukemia

Multiple Myeloma

Top Venues

Journal of American college health : J of ACH

PharmacoEconomics - open

Expert review of hematology

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Katherine A Hicks, Parinaz K Ghaswalla, Justin Carrico, Seri Anderson, Patricia Novy, Cosmina S Hogea, Mary S Hayney
Estimating the cost of university-based outbreaks of serogroup B meningococcal disease with different pre-matriculation vaccination policies in the United States. Journal of American college health : J of ACH (2023)
Katherine A Hicks, Parinaz K Ghaswalla, Justin Carrico, Seri Anderson, Patricia Novy, Cosmina S Hogea, Mary S Hayney
Estimating the cost of university-based outbreaks of serogroup B meningococcal disease with different pre-matriculation vaccination policies in the United States. Journal of American college health : J of ACH (2023)
Andreas Nikolaou, Apoorva Ambavane, Anshul Shah, Wenkang Ma, Jon Tosh, Venediktos Kapetanakis, Jenny Willson, Feng Wang, Cosmina S Hogea, Boris Gorsh, Ben Gutierrez, Sandhya Sapra, Attaya Suvannasankha, Yevgeniy Samyshkin
Belantamab mafodotin for the treatment of relapsed/refractory multiple myeloma in heavily pretreated patients: a US cost-effectiveness analysis. Expert review of hematology (2021)
Diana Garbinsky, Shannon Hunter, Elizabeth M La, Sara Poston, Cosmina S Hogea
State-Level Variations and Factors Associated with Adult Vaccination Coverage: A Multilevel Modeling Approach. PharmacoEconomics - open 5 (3) (2021)
Sandra E Talbird, Elizabeth M La, Justin Carrico, Sara Poston, Jean-Etienne Poirrier, Jessica K DeMartino, Cosmina S Hogea
Impact of population aging on the burden of vaccine-preventable diseases among older adults in the United States. Human vaccines & immunotherapeutics 17 (2) (2020)